Low incidence of second neoplasms among children diagnosed with acute lymphoblastic leukemia after 1983.

@article{Bhatia2002LowIO,
  title={Low incidence of second neoplasms among children diagnosed with acute lymphoblastic leukemia after 1983.},
  author={Smita Bhatia and Harland N. Sather and Olga B Pabustan and Michael e. Trigg and Paul S. Gaynon and Leslie L. Robison},
  journal={Blood},
  year={2002},
  volume={99 12},
  pages={4257-64}
}
Second malignant neoplasms are a serious complication after successful treatment of childhood acute lymphoblastic leukemia (ALL). With improvement in survival, it is important to assess the impact of contemporary risk-based therapies on second neoplasms in ALL survivors. A cohort of 8831 children diagnosed with ALL and enrolled on Children's Cancer Group therapeutic protocols between 1983 and 1995 were observed to determine the incidence of second neoplasms and associated risk factors. The… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 62 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 60 references

Dexamethasone (DEX) decreases central nervous system (CNS) relapse and improves event-free survival (EFS) in lower risk acute lymphoblastic leukemia (ALL) [abstract

  • B Bostrom, P Gaynon, H. Sather
  • Proc Am Soc Clin Oncol
  • 1998

Similar Papers

Loading similar papers…